Lenvima 10mg Capsule is used for the treatment of thyroid cancer. Take it with or without food, preferably at the same time each day. Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn't stop or if you find blood in your stools.
Thyroid is a butterfly-shaped gland located at the base of your neck. Your thyroid produces hormones that regulate your heart rate, blood pressure, body temperature and weight. Thyroid cancer occurs in the cells of the thyroid and it might not cause any symptoms at first. Lenvima 10mg Capsule restricts the oxygen supply of the cancer cells and stops its growth as well as further spread. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
The person is at greater risk if:
Lenvima 10mg Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits.
Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time.
You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects.
Take the missed dose as soon as you remember. If it is almost 12 hours due for the next scheduled dose, then the missed dose can be skipped.
Contact your doctor for further instructions if you miss more than one scheduled dose of this medicine.
Ques: What is Lenvima 10mg Capsule used to treat?
Ans:Lenvima 10mg Capsule is a prescription medicine that is used to treat people with certain kinds of cancer. LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.
Ques: How effective is Lenvima 10mg Capsule?
Ans:Lenvima 10mg Capsule has been shown to be at least as effective as the cancer medicine sorafenib at prolonging the time patients lived in one main study. The study involved 954 patients with hepatocellular carcinoma who had not previously been treated for their cancer and whose cancer could not be removed by surgery.